Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | P14 - Poster Session 14

Thursday 04/30/20
08:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology
0.00 credit
Event Timeline
08:00 AM - 09:00 AM Abstract 9-001 - Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis Mice
Suyog U. Pol, PhD
08:00 AM - 09:00 AM Abstract 9-002 - Effectiveness of Subcutaneous Tocilizumab therapy in Neuromyelitis Optica Spectrum Disorder
Itay Lotan, MD
08:00 AM - 09:00 AM Abstract 9-003 - Neurofilament Light Chain Levels in Patients with Antibodies to Myelin Oligodendrocyte Glycoprotein (MOG-Ab)
Sara Mariotto, MD, PhD
08:00 AM - 09:00 AM Abstract 9-004 - Neuromyelitis Optica Spectrum Disorders Misdiagnosed as Multiple Sclerosis: Can Current Diagnostic Guidelines Separate the Two Diseases?
Maria Sokola, MD
08:00 AM - 09:00 AM Abstract 9-005 - When Tissue is an Issue: "Trident Sign" Enhancement Helps Diagnose Sarcoid Myelopathy
Chris Hollen, MD
08:00 AM - 09:00 AM Abstract 9-006 - Predictors of Diagnosis and Outcome in Pediatric MOG-antibody Associated Disorders
Duriel I. Hardy, MD
08:00 AM - 09:00 AM Abstract 9-007 - Differential expression of soluble cerebrospinal fluid, serum, and cell surface markers in neuromyelitis optica spectrum disorder
08:00 AM - 09:00 AM Abstract 9-008 - Frequency of optic nerve lesions on MRI in acute optic neuritis associated with neuromyelitis optica spectrum disorders in a Latin American cohort
Juan Ignacio Rojas, MD
08:00 AM - 09:00 AM Abstract 9-009 - Risk factors related to relapse after first immunosuppressive treatment in patients with neuromyelitis optica spectrum disorders
Fernando Morales-Ramírez
08:00 AM - 09:00 AM Abstract 9-010 - Characterization of T cells in NMOSD patients - an emerging role for T cells in disease pathogenesis
Luisa H. Klotz, MD
08:00 AM - 09:00 AM Abstract 9-011 - Bilaterally Synchronized Faciobrachial Dystonic Seizures in Anti-LGI1 Encephalitis: A Case Report
Takahisa Mikami, MD
08:00 AM - 09:00 AM Abstract 9-012 - Natalizumab Maintains Remission in a Patient with MOG Antibody Disease
Rebecca L. Gillani, MD
08:00 AM - 09:00 AM Abstract 9-013 - Menstrual and Reproductive History in Neuromyelitis Optica Spectrum Disorder (NMOSD): a cross-sectional analysis using the EnvIMS questionnaire
08:00 AM - 09:00 AM Abstract 9-014 - Immigration, Childhood Sunlight Exposure, and Risk of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Dina Dababneh, MD
08:00 AM - 09:00 AM Abstract 9-015 - An Unusual Presentation of Acute Psychosis in an Elderly Patient with Inflammatory Cerebral Amyloid Angiopathy
Leila Ghaffari, MD
08:00 AM - 09:00 AM Abstract 9-016 - Rare Case of Neuro-Behçet’s Syndrome in an Adult Male .
08:00 AM - 09:00 AM Abstract 9-017 - Identifying Gaps in Knowledge, Skill and Confidence Among MS Specialists to Facilitate Appropriate Evolutions in MS Care
Klaus Schmierer, MD, PhD
08:00 AM - 09:00 AM Abstract 9-018 - Multiple Sclerosis Disease-Modifying Therapy: Recent Switch Patterns Among United States Neurologists
Patricia K. Coyle, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 9-019 - Study for the Validation of the FeetMe® Integrated Sensor Insole System Compared to GAITRite® System to Assess the Characteristics of the Gait in Patients with Multiple Sclerosis
08:00 AM - 09:00 AM Abstract 9-020 - Changing Patterns in Disease-Modifying Therapy Selection for Treatment-Naive Multiple Sclerosis in the United States
Patricia K. Coyle, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 9-021 - Association of Serum Neurofilament Biomarker Levels with Quality of Life and Healthcare Utilization in Patients with Multiple Sclerosis
Kristin M. Galetta, MD
08:00 AM - 09:00 AM Abstract 15-001 - A Case of anti-MOG Associated Disease Presenting With Palatal Myoclonus And Extensive Bilateral Cortical-Based Inflammation
Jafar Hashem, MD
08:00 AM - 09:00 AM Abstract 15-002 - Neuromyelitis Optica Spectrum Disorder (NMOSD): Epidemiology, Treatments, and Outcomes in a Single Center
Robert Kadish, MD
08:00 AM - 09:00 AM Abstract 15-003 - An aggressive presentation of aquaporin-4 neuromyelitis spectrum disorder in a 2-year-old girl: challenges in diagnosis and treatment.
Tuba Rashid Khan, MD
08:00 AM - 09:00 AM Abstract 15-004 - Comparative Immune Cell and Cytokine Phenotyping in Neuromyelitis Optica Spectrum Disorder Patients from the CIRCLES Cohort
Soumya S. Yandamuri, PhD
08:00 AM - 09:00 AM Abstract 15-005 - Harnessing the power of social media to learn about a very rare disorder: survey of Facebook group about paroxysmal symptoms in Neuromyelitis Optica Spectrum Disorder
Itay Lotan, MD
08:00 AM - 09:00 AM Abstract 15-006 - Adolescents with NMOSD Achieved Similar Exposures and Favorable Safety Profile when Treated with the Adult Satralizumab Dosing Regimen
Cheryl Hemingway
08:00 AM - 09:00 AM Abstract 15-007 - Characterisation of the PK and PD of Satralizumab, a Recycling Antibody, to Support Q4W Dosing in Patients with NMOSD
Sian Lennon-Chrimes
08:00 AM - 09:00 AM Abstract 15-008 - Infection Risk in Patients with Complement-Mediated Neurological Disorders Receiving Eculizumab: Findings from Two Phase 3 Studies and Their Extensions in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+ NMOSD) and Acetylcholine-Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis (AChR+ gMG)
Todd D. Levine, MD
08:00 AM - 09:00 AM Abstract 15-009 - The impact of relapses on quality of life in patients with neuromyelitis optica spectrum disorder: data from the phase 3 PREVENT study
Achim Berthele, MD
08:00 AM - 09:00 AM Abstract 15-010 - Impact of Eculizumab on Disability Worsening and Quality of Life in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Results from the Phase 3 PREVENT Study
Jacqueline Palace
08:00 AM - 09:00 AM Abstract 15-011 - Impact of Eculizumab on Health Outcomes in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings from the PREVENT Study
Achim Berthele, MD
08:00 AM - 09:00 AM Abstract 15-012 - Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study
Kazuo Fujihara, MD
08:00 AM - 09:00 AM Abstract 15-013 - Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study
Ho Jin Kim, MD
08:00 AM - 09:00 AM Abstract 3-001 - Predictive Factors Of Disease Progression In Parkinson’s Disease In A Tunisian Cohort
08:00 AM - 09:00 AM Abstract 3-002 - Visual-Spatial Dysfunction in Parkinson’s Disease: an Exploratory Multimodal Biomarker Study
Alberto Cucca, MD
08:00 AM - 09:00 AM Abstract 3-003 - Trends in the Incidence of Parkinson’s disease diagnosis between 2006 and 2016: Analysis of a large UK Primary care database.
08:00 AM - 09:00 AM Abstract 3-004 - Implications of Gut Microbiome Dysbiosis in Parkinson's Disease: A Literature Review.
Mohamed Elfil, MBBCh
08:00 AM - 09:00 AM Abstract 3-005 - Microbiome characterization and reversal of dysbiosis in Parkinson’s disease by Fecal Microbiota Transplantation
08:00 AM - 09:00 AM Abstract 3-006 - Prevalence of Cognitive impairment in Mexican patients with Parkinson’s Diseases.
Oscar Esquivel, MD
08:00 AM - 09:00 AM Abstract 3-007 - Factors associated with Freezing of Gait in Parkinson's Disease: A multi-centric Mexican cohort
08:00 AM - 09:00 AM Abstract 3-008 - How many adults in the US have essential tremor? Using data from epidemiological studies to derive age-specific estimates of prevalence.
08:00 AM - 09:00 AM Abstract 3-009 - Efficacy and Safety of CX-8998 in T-CALM, a Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial in Participants With Essential Tremor: Subgroup Analysis by Baseline Tremor Severity
H. A. Jinnah, MD, PhD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 3-010 - The Clinical Role of Jaw Tremor in Movement Disorders
Sana Aslam, DO
08:00 AM - 09:00 AM Abstract 3-011 - Clinical and neuropsychological correlates of the TETRAS score in DBS patients
Steven T. Bellows, MD
08:00 AM - 09:00 AM Abstract 3-012 - Are cerebellar signs seen in pre-manifest essential tremor cases? A study of unaffected first-degree relatives of cases
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 3-013 - Quantitative Tremor Analysis of Functional Tremor
Fan Zhang, DO
08:00 AM - 09:00 AM Abstract 3-014 - Characterizing Quality of Life Post-Deep Brain Stimulation (DBS) using EQ-5D-5L
Mya C. Schiess, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 3-015 - Primary Orthostatic Tremor Treated Successfully with Perampanel
08:00 AM - 09:00 AM Abstract 3-016 - Patient-Reported “Good” Days During a Prospective Study of the Treatment of Neurogenic Orthostatic Hypotension With Droxidopa
Steven Kymes
08:00 AM - 09:00 AM Abstract 3-017 - Treatment of Medication-Refectory Holmes Tremor by Simultaneous Thalamic Ventral Intermediate (VIM) Nucleus and Subthalamic Nucleus (STN) Deep Brain Stimulation-A Case Report
Muhammad W. Anjum, MD
08:00 AM - 09:00 AM Abstract 12-001 - Efficacy and Safety of Adjunctive Perampanel in South Korean Patients with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS): Post Hoc Analysis of Phase II and III Double-Blind and Open-Label Extension (OLEx) Studies
Manoj Malhotra, MD
08:00 AM - 09:00 AM Abstract 12-002 - Efficacy and Safety of Perampanel Monotherapy in Patients with Newly Diagnosed or Currently Untreated Recurrent Partial-Onset Seizures (POS): Final Analysis of Study 342 (FREEDOM) 4 and 8 mg/day Core Data
Takamichi Yamamoto, MD, PhD, FAES
08:00 AM - 09:00 AM Abstract 12-003 - Antiepileptic Drug (AED) Treatment in Juvenile Myoclonic Epilepsy (JME): a Population-based Study
Ahyuda Oh, PhD
08:00 AM - 09:00 AM Abstract 12-004 - E-cigarette Use (Vaping) Causes Seizures on EEG detected by Responsive Neurstimulation : Evidence from Electrocorticography
Joel M. Oster, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 12-005 - Patient, Caregiver, and Healthcare Professional Perspectives on Seizure Freedom, Seizure Control, and Treatment Goals
Danielle A. Becker, MD
08:00 AM - 09:00 AM Abstract 12-006 - Transition from Pediatric to Adult Epilepsy Care: A Multi-Disciplinary Approach
Nassim Zecavati, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 12-007 - Characterizing the Phenotype of Epilepsy in Children with Past Leukemia
Elham Abushanab, MD
08:00 AM - 09:00 AM Abstract 12-008 - Readmissions for Cardiac and Non-cardiac Causes Among those with Epilepsy or Multiple Sclerosis
Hernan Nicolas Lemus Esquivel, MD
08:00 AM - 09:00 AM Abstract 12-009 - Neuro Critical Care Models Improve Outcomes in Epilepsy & Certified Stroke Centers
Angela M. Hawkins, RN
08:00 AM - 09:00 AM Abstract 6-001 - Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP): A Database Analysis
Cagdas Erdogan
08:00 AM - 09:00 AM Abstract 6-002 - Genetic Testing for Hereditary ATTR Amyloidosis: Insights from the hATTR Compass Program
Sami L. Khella, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 6-003 - High Prevalence of Transthyretin-Related Amyloidosis in Crete, Greece is Due to Three TTR Pathogenic Variants with Markedly Differing Phenotypic Presentations
MINAS TZAGOURNISAKIS
08:00 AM - 09:00 AM Abstract 6-004 - Relationships Between Forced Vital Capacity and Respiratory Sub-domain Scale on the ALSFRS-R
08:00 AM - 09:00 AM Abstract 6-005 - Quantitative Magnetisation Transfer Brain Imaging Reveals Altered Biological Integrity of Motor Regions in Amyotrophic Lateral Sclerosis
08:00 AM - 09:00 AM Abstract 6-006 - Clinical Characteristics of Patients with Motor Neuron Diseases in a Tertiary Health Care Centre in Abuja, Nigeria
Nkechi Obianozie, MBBS
08:00 AM - 09:00 AM Abstract 6-007 - Genetic testing utilization for patients with neurological disease: limitations of using claims data
Samuel J. Mackenzie, MD, PhD
08:00 AM - 09:00 AM Abstract 6-008 - Machine Learning Model for Prognostication of 90-day Patient Outcome Immediately after Thrombectomy in Acute Ischemic Stroke Patients
Srinivasa Rao Kundeti
08:00 AM - 09:00 AM Abstract 6-009 - Functional Outcome and Clinical Characteristics of Stroke survivors with early-onset post stroke seizures in a semi-urban area in Kogi State, Nigeria.
Babatunde A. Ademiluyi, MD
08:00 AM - 09:00 AM Abstract 7-001 - Establishing Responder Definitions for Short-form Headache Impact Test (HIT-6) Total and Item Scores in Chronic Migraine
Carrie R. Houts
08:00 AM - 09:00 AM Abstract 7-002 - Differences in Exposure Between Intravenously (IV) Administered Eptinezumab and Subcutaneously (SC) Administered CGRP Inhibitor Monoclonal Antibodies After Single Therapeutic Doses
08:00 AM - 09:00 AM Abstract 7-003 - Correlation Analysis of the Change in SF-36 with Change in Patient-Identified Most Bothersome Symptom and Monthly Migraine Days (MMDs) in Patients with Chronic Migraine (CM): Results of the PROMISE-2 Study
William B. Young, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-004 - Utilization of Smartphone Based Migraine Tracking with a Free Text Feature: A Retrospective Analysis
08:00 AM - 09:00 AM Abstract 7-005 - Characterization of Transit Times in the Large Intestine of Mice Following Treatment with a CGRP Antibody, CGRP Receptor Antibody and a Small Molecule CGRP Receptor Antagonist
Kirk W. Johnson, PhD
08:00 AM - 09:00 AM Abstract 7-006 - Water-insoluble Mucoadhesive Formulation Enables Consistent and Rapid Intranasal Absorption of Drugs, Including Granisetron, Zolmitriptan and Dihydroergotamine
Fumiyoshi Iwashima
08:00 AM - 09:00 AM Abstract 7-007 - Psychometric Evaluation of the Functional Impact of Migraine Questionnaire Within the COMPEL Trial
Pranav Gandhi
08:00 AM - 09:00 AM Abstract 7-008 - Pharmacokinetic Comparison of STS101, an Intranasal Dry Powder Formulation of Dihydroergotamine, with Other Intranasal, Injectable and Oral Inhaled DHE Formulations
Shannon Strom
08:00 AM - 09:00 AM Abstract 7-009 - Comparison of Early Plasma Exposure to DHE for Marketed and Development Stage Nasal, Inhalation, and Injectable Products
Kelsey Satterly
08:00 AM - 09:00 AM Abstract 7-010 - Development of a Text Message-based Headache Diary in Adolescents and Children
Danielle J. Kellier
08:00 AM - 09:00 AM Abstract 1-001 - Corneal Nerve Fiber Length In Hereditary Transthyretin Amyloidosis Polyneuropathy
Monica Alcantara, MD
08:00 AM - 09:00 AM Abstract 1-002 - Peripheral Neuropathy outcome after 2-years of treatment with tafamidis in patients with only small fiber symptoms and non-Val30Met hATTR amyloidosis.
Maria Alejandra Gonzalez Duarte, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 1-003 - Neurological Manifestations in Patients with Hereditary Transthyretin Amyloidosis: A Retrospective Database Study Based at a Major Multidisciplinary Amyloidosis Center
Shivkumar Bhadola, MD
08:00 AM - 09:00 AM Abstract 1-005 - Poor Yield of Routine Transthyretin Genetic Screening in Patients with Idiopathic Neuropathy
Dina Namiranian, MD
08:00 AM - 09:00 AM Abstract 1-006 - Reducing Axonal Firing Induces Sustained Pain Remission and Axonal Regrowth in SCN9A Variant Small-fiber Neuropathy
Madeleine Klein, BS
08:00 AM - 09:00 AM Abstract 1-007 - Episodic Psychosis, Ataxia, Motor Neuropathy Caused by a Novel Mutation in ADPRHL2
Hacer Durmus, MD
08:00 AM - 09:00 AM Abstract 1-008 - Case Series: Pediatric Patients with Concomitant Genetic Neuropathy Syndromes and Immune Mediated Polyneuropathy.
Norianne Pimentel, MD
08:00 AM - 09:00 AM Abstract 1-009 - NUDT2 Associated Syndrome with Developmental Delay and Peripheral Neuropathy.
Shrikant Mishra, MD
08:00 AM - 09:00 AM Abstract 1-010 - A Mitochondrial tRNA Mutation Causes Axonal Charcot-Marie-Tooth Disease in a Large Family from the Venezuelan Andes
Alexander J. Fay, MD, PhD
08:00 AM - 09:00 AM Abstract 1-011 - Respiratory Insufficiency as a Feature of MORC2 Gene-Related Charcot-Marie-Tooth Disease Type 2: A Case Report
Gregory Fenton, MD
08:00 AM - 09:00 AM Abstract 1-012 - A Novel SPG11 mutation causing Charcot- Marie-Tooth Disease Type 2
Nirav Sanghani, MBBS
08:00 AM - 09:00 AM Abstract 1-013 - Conduction Block in Charcot-Marie Tooth Neuropathy Type 4J
Jacqueline Li, MD
08:00 AM - 09:00 AM Abstract 1-014 - Acute Intermittent Porphyria Associated With Reversible Posterior Encephalopathy Syndrome: A Rare Presentation
Sandra M. Torres, Sr., MD
08:00 AM - 09:00 AM Abstract 10-001 - Looking for Light: Paradichlorobenzene Toxicity in a 30 Year-Old Woman Following Long Term Ingestion of Mothballs
Abigail Lofchie, MD
08:00 AM - 09:00 AM Abstract 10-002 - Fatigue in Multiple Sclerosis: Relation with Clinical and Neuropsychological Variables, Brain MRI Lesions and Atrophy
Carmen Vizzino
08:00 AM - 09:00 AM Abstract 10-003 - Pilot Investigation of the Relationship Between Hippocampal Volumes and Memory Deficits in Progressive Multiple Sclerosis (pMS)
Julia Rybkina
08:00 AM - 09:00 AM Abstract 10-004 - Predicting Longitudinal Cognitive Decline in MS Using Baseline Clinical Routine T2-FLAIR MRI
Tom Fuchs
08:00 AM - 09:00 AM Abstract 10-005 - The Challenge of Maintaining Therapeutic Benefits over the Long Term: Example of Adding 4 Reactivation Sessions to a Cognitive-Behavioural Fatigue Management Program for People with Relapsing-Remitting Multiple Sclerosis.
08:00 AM - 09:00 AM Abstract 10-006 - Intake of high saturated fat foods predicts cognitive change in the Women’s Interagency HIV Study (WIHS)
Lakshmi Warrior, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 10-007 - Body mass index and leptin are associated with executive function over 10 years in women with and without HIV infection. The Women’s Interagency HIV Study (WIHS)
Francesca Macaluso
08:00 AM - 09:00 AM Abstract 10-008 - The Effects of Methylphenidate on Creativity in Individuals with Attention Deficit Hyperactivity Disorder
Alinna J. Sam
08:00 AM - 09:00 AM Abstract 10-009 - A Novel Approach for Reducing Stress in Veterans with PTSD and Depression: Improving Awareness and Detection of Central Auditory Processing Disorder
Eliot A. Licht, MD
08:00 AM - 09:00 AM Abstract 10-010 - SAGE-217 in Major Depressive Disorder: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Koji Takahashi, PhD
08:00 AM - 09:00 AM Abstract 10-011 - Catatonia Misdiagnosed as Creutzfeldt–Jakob disease
Syeda Maria Muzammil, MD
08:00 AM - 09:00 AM Abstract 4-001 - Long Term Outcome Of Patients With Unruptured Aneurysms Treated by Alteplase Due to Ischemic Stroke
08:00 AM - 09:00 AM Abstract 4-002 - Dural Arteriovenous Fistula Presenting as an Unusual Cause of Tongue Atrophy
Bhageeradh Mulpur, MD
08:00 AM - 09:00 AM Abstract 4-003 - Tadalafil-Associated Recurrent Intracerebral Hemorrhage
Tyler Koehn, MD
08:00 AM - 09:00 AM Abstract 4-004 - Spinal Dural Arterio-Venous Fistula: A Masquerade as a Longitudinal Myelitis
Amardeep Saund, MD
08:00 AM - 09:00 AM Abstract 4-005 - Predictors of good functional outcome after hemorrhagic stroke
Jessica Houck, DO
08:00 AM - 09:00 AM Abstract 4-006 - Delayed Vasospasm in Traumatic Subarachnoid Hemorrhage
Rohan Sharma, MD
08:00 AM - 09:00 AM Abstract 4-007 - Spontaneous intracranial hemorrhage and acute multiple bilateral subcortical infarcts, a case of possible CADASIL
Chen Chen, MD
08:00 AM - 09:00 AM Abstract 4-008 - Ischemic stroke as a complication of cannabis use: a systematic review
Ibrahim Migdady, MD
08:00 AM - 09:00 AM Abstract 4-009 - A Global First: Assessment of Sleep Apnoea and Select Sleep Disorders in an African Cohort
N. Abimbola Sunmonu, MD, PhD
08:00 AM - 09:00 AM Abstract 4-010 - Predictors of Stroke Mortality among Patients Admitted to a Hospital in Ethiopia
08:00 AM - 09:00 AM Abstract 4-011 - Relationship between the severity of Obstructive Sleep Apnea syndrome and the intima media thickening of common carotid artery in patients with stroke
Horacio Chapa-Martinez
08:00 AM - 09:00 AM Abstract 4-012 - Changing Face Of Carotid Revascularization Procedures In The United States
Hamza I. Maqsood, MD
08:00 AM - 09:00 AM Abstract 4-013 - Carotid Artery Stent Placement via Radial Arterial Route
Vamshi Krishna Sai Balasetti, MD
08:00 AM - 09:00 AM Abstract 4-014 - Balloonless Carotid Stenting – a Novel Approach to Reducing Peri-Operative Stroke Risk
08:00 AM - 09:00 AM Abstract 4-015 - Risk Factors for Recurrence of Vascular Events in Middle-Aged Stroke Survivors
Kevin N. Vanent
08:00 AM - 09:00 AM Abstract 4-016 - Guideline-Recommended Cancer Screening in Adults with Stroke: A Nationwide Analysis
Stephanie Rutrick, MD
08:00 AM - 09:00 AM Abstract 4-017 - Baseline Differences in Risk Factor Control and Medication Use Between 2 Trials Employing Intensive Medical Management (SAMMPRIS & CREST2)
Tanya N. Turan, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 4-018 - Association Between Lipoprotein(a) Concentration and the Risk of Stroke in the Chinese Han Population: a Retrospective Case-control Study
08:00 AM - 09:00 AM Abstract 4-019 - Diet Pattern in Acute Stroke Patients, a Semiquantitative Analysis
Laurel J. Cherian, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 4-020 - Serum Alpha-1 Antitrypsin and atherosclerosis burden in patients with acute ischemic stroke
Ali Mahta, MD
08:00 AM - 09:00 AM Abstract 4-021 - Intracranial Arterial Dolichoectasia in Patients with Ischemic Stroke: Preliminary Results From the IDEAS Study
Victor J. Del Brutto, MD
08:00 AM - 09:00 AM Abstract 13-001 - Introducing High-fidelity Acute Neurology Simulation for Medical Students
Ramdinal A. Zairinal, MD
08:00 AM - 09:00 AM Abstract 13-002 - Early Electrographic Seizure Detection by Neuro ICU Nurses via Bedside Real-Time Quantitative EEG
Safa Kaleem, MD
08:00 AM - 09:00 AM Abstract 13-003 - Implementation of a Quantitative Electroencephalography Curriculum for Seizure Detection in the Pediatric Intensive Care Unit - A Quality Improvement Initiative
Daniel Davila-Williams, MD
08:00 AM - 09:00 AM Abstract 13-004 - EEG Monitoring for the Detection of Subclinical Seizures in the Pediatric Intensive Care Unit – A Quality Improvement Project
Jamie Ghossein
08:00 AM - 09:00 AM Abstract 13-005 - Predictors of Functional Outcomes in Status Epilepticus
Matthew R. Woodward, DO
08:00 AM - 09:00 AM Abstract 13-006 - Ictal-Interictal Continuum In Toxic Metabolic Encephalopathy: Prevalence and Outcomes
Maryum Shoukat, MD
08:00 AM - 09:00 AM Abstract 13-007 - Adjunctive Perampanel in Refractory Status Epilepticus (RSE): A Report of Two Cases.
Xin Yang, MD, PhD
08:00 AM - 09:00 AM Abstract 13-008 - Effect of seizures on outcomes in patient with cardiac surgery
Vishwanath Sagi, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 13-009 - Reliability of EEG Reactivity in the Assessment of Comatose Patients Under Standardized Protocol
Derek Debicki, MD
08:00 AM - 09:00 AM Abstract 13-010 - Potency and Safety of Ketamine in Neuro-critical Care Intensive care Unit- A Single Centre experience
Premkumar Nattanmai Chandrasekaran, MD
08:00 AM - 09:00 AM Abstract 13-011 - How Much Propofol Treats Status Epilepticus ?
Joel M. Oster, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 13-012 - Cerebral edema with Refractory Intracranial Hypertension Secondary to Lamotrigine Overdose
Madihah A. Hepburn, MD
08:00 AM - 09:00 AM Abstract 13-013 - Goals-Of-Care Decision Aid for Critically Ill TBI Patients: Development and Feasibility Testing
Susanne Muehlschlegel, MD, MPH, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 13-014 - Gabapentin Role in Improving outcome of Patients with Severe Traumatic Brain Injury (GRIPs TBI)
Rebekah Proctor
08:00 AM - 09:00 AM Abstract 13-015 - Traumatic Interhemispheric Subdural Hematomas – clinical significance, management and outcome.
Etienne Leveille, MD
08:00 AM - 09:00 AM Abstract 13-016 - Quantitative Pupillometry and Intracranial Pressure in Neuro ICU Patients
Meghan Hutch
08:00 AM - 09:00 AM Abstract 13-017 - Temporal and spatial patterns of inflammation and oxidative injury in human SCI
Tobias Zrzavy
08:00 AM - 09:00 AM Abstract 13-018 - The Neuroemergencies Management and Transfers (NEMAT) Program: A System of Care to Improve Outcomes for Patients Transferred for Neurological Emergencies
Neha Dangayach, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 5-001 - Concomitant Medication in Adolescent and Adult Individuals with Angelman Syndrome: Baseline Results from the Phase 2 STARS Study
08:00 AM - 09:00 AM Abstract 5-002 - The Neurodevelopmental and Motor Phenotype of SCA21 (ATX-TMEM240)
Emma Burdekin
08:00 AM - 09:00 AM Abstract 5-003 - The Phase 2a ROCKET trial investigating gaboxadol in adolescents and young adults with Fragile X Syndrome: Study design
Dejan Budimirovic
08:00 AM - 09:00 AM Abstract 5-004 - Trofinetide: A Novel Approach to Rett Syndrome
Jeffrey Neul, MD, PhD
08:00 AM - 09:00 AM Abstract 5-005 - Alpha- mannosidosis masquerading as familial macrocephaly
Surabhi Kaul, MD
08:00 AM - 09:00 AM Abstract 5-006 - Uridine Supplementation for Treatment of Epileptic Encephalopathy from Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase and Dihydroorotase (CAD) Gene Mutation
Aliya Frederick, MD, PhD
08:00 AM - 09:00 AM Abstract 5-007 - A Case of progressive leukodystrophy and congenital deafness?associated?with?KARS mutation
Anuradha Singh, DO
08:00 AM - 09:00 AM Abstract 5-008 - Expanding the phenotypic spectrum of dopamine transporter deficiency syndrome with a novel mutation
08:00 AM - 09:00 AM Abstract 5-009 - Developing targeted therapies for epileptic encephalopathy due to SYNGAP1 mutations
Jimmy Holder, MD
08:00 AM - 09:00 AM Abstract 5-010 - Evaluation of the association between the age of onset and duration of epilepsy, and the neuropsychological and developmental performance, in patients with refractory epilepsy, at the Costa Rica National Children's Hospital Epilepsy Monitoring Unit: a 13-year hospital-based retrospective cohort.
Sixto Bogantes Ledezma, MD
08:00 AM - 09:00 AM Abstract 5-011 - Perampanel associated with developmental regression in patient with FRRS1L mutation
Chen Yan, MD
08:00 AM - 09:00 AM Abstract 5-012 - Atypical abnormal eye movements in PNPO-related epilepsy
Sara Pavitt, MD
08:00 AM - 09:00 AM Abstract 5-013 - Sexual and Reproductive Health in Adolescent and Young Adult Women with Epilepsy: a Qualitative Study of Pediatric Neurologists and Epileptologists
Laura A. Kirkpatrick, MD
08:00 AM - 09:00 AM Abstract 5-014 - Nonepileptic Events in Children and Adolescents in New Onset Seizure Clinic
Faculty Disclosures
Dean M. Wingerchuk, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
David M. Greer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Michael Levy, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
David Y. Hwang, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.
Bart Demaerschalk, MD, MSc, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Patricia K. Coyle, MD, FÂ鶹´«Ã½Ó³»­ Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Anette E. Schrag, MD Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer ingelheim. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Schrag has received research support from NIHR, EU, Parkinson's UK, MDS.
Tatjana Rundek, MD, PhD The institution of Dr. Rundek has received research support from NIH.
Nathalie Jette, MD, MSc, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Brian Callaghan, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from Â鶹´«Ã½Ó³»­. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIA. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Audrey Leasure Ms. Leasure has nothing to disclose.
Guido J. Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Tanuja Chitnis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Ilya Kister, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Sean J. Pittock, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Ibrahim Migdady, MD Dr. Migdady has nothing to disclose.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Thomas G. Brott, MD, FÂ鶹´«Ã½Ó³»­ Dr. Brott has nothing to disclose.
Lori A. Shutter, MD, FCCM, FNCS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Shutter has received research support from NIH. Dr. Shutter has received publishing royalties from a publication relating to health care.
Brent L. Fogel, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Deborah Gustafson, PhD, MS The institution of Deborah Gustafson, PhD, MS has received research support from National Institutes of Health.
Bradford B. Worrall, MD, MSc, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Rajesh Pahwa, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Deborah M. Green-LaRoche, MD The institution of Dr. Green-LaRoche has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Clinical Trials. Dr. Green-LaRoche has received publishing royalties from a publication relating to health care.
Osvaldo J. Nascimento, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nascimento has nothing to disclose.
H.-Christian C. von Büdingen, MD, FÂ鶹´«Ã½Ó³»­ Dr. von Büdingen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. von Büdingen has stock in F. Hoffmann-La Roche Ltd.
Rufus O. Akinyemi, MD Dr. Akinyemi has nothing to disclose.
Joel M. Oster, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Oster has received research support from Marinus Pharmaceuticals.
Camilo R. Gomez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gomez has nothing to disclose.
Anne Louise Oaklander, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Oaklander has received research support from National Institutes of Health.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Leila Maybodi, MD No disclosure on file
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Mya C. Schiess, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schiess has nothing to disclose.
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Christopher P. Kellner, MD Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Kelly E. Lyons, PhD Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parkinson's Foundation. Dr. Lyons has a non-compensated relationship as a President with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Nizar Souayah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Peter Hedera, MD Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
H. A. Jinnah, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
No disclosure on file
Joshua A. Kornbluth, MD Dr. Kornbluth has received personal compensation for serving as an employee of Tufts Medical Center. Dr. Kornbluth has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ERI. Dr. Kornbluth has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. The institution of Dr. Kornbluth has received research support from Vivonics, Inc.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Derek Debicki, MD Dr. Debicki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Canada Inc.. The institution of Dr. Debicki has received research support from Academic Medical Association of Southwestern Ontario. The institution of Dr. Debicki has received research support from Western BrainScan. The institution of Dr. Debicki has received research support from Lawson Research. The institution of Dr. Debicki has received research support from Canadian Institutes of Health Research.
Sarah Hopkins, MD The institution of Dr. Hopkins has received research support from NIH. The institution of Dr. Hopkins has received research support from CDC.
Erik P. Pioro, MD, DPhil, FÂ鶹´«Ã½Ó³»­ Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Mayowa Owolabi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Owolabi has nothing to disclose.
Jessica E. Rexach, MD, PhD Dr. Rexach has nothing to disclose.
Harold H. Morris III, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Robert D. Brown, Jr., MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Shyamal Mehta, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
Ichiro Nakashima, MD, PhD Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. The institution of Dr. Nakashima has received research support from LSI Medience. The institution of Dr. Nakashima has received research support from BML.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Nitish Kumar, MD Dr. Kumar has nothing to disclose.
Riwanti Estiasari No disclosure on file
Saloua Mrabet, MD Dr. Mrabet has nothing to disclose.
Laurel J. Cherian, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cherian has received research support from NIH.
Prakash Kotagal, MD, MBBS, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Peter N. Leigh, BSc, MB, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Peter K. Todd, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Todd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REATA Therapeutics. Dr. Todd has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal services. Dr. Todd has or had stock in Denali Therapeutics. The institution of Dr. Todd has received research support from NIH. The institution of Dr. Todd has received research support from VA. The institution of Dr. Todd has received research support from Ann Arbor Against ALS. The institution of Dr. Todd has received research support from Packard Foudation. Dr. Todd has received intellectual property interests from a discovery or technology relating to health care. Dr. Todd has received publishing royalties from a publication relating to health care. Dr. Todd has received personal compensation in the range of $500-$4,999 for serving as a ANA Highlights module director with American Neurological Association.
Mark G. Stefanelli, MD No disclosure on file
John T. Farrar, MD Dr. Farrar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Farrar has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PharamcoEpidemiology and Drug Safety. The institution of Dr. Farrar has received research support from Food and Drug Administration . The institution of Dr. Farrar has received research support from NIH .
Neal S. Parikh, MD Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
Julian Martinez Agosto, MD, PhD Julian Martinez Agosto, MD, PhD has nothing to disclose.
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Alan K. Percy, MD, FÂ鶹´«Ã½Ó³»­ Dr. Percy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Percy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Percy has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurogene. Dr. Percy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha Gene Therapies. Dr. Percy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS Press.
Nirav Sanghani, MBBS Dr. Sanghani has nothing to disclose.
Hooman Kamel, MD Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Kimberly L. Panizzon No disclosure on file
Shafali Jeste, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Elia M. Pestana Knight, MD Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus Pharmaceuticals.
Ahsan M. Naduvil Valappil, MD Dr. Naduvil Valappil has nothing to disclose.
Tanya N. Turan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Turan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer/Merck. Dr. Turan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore Inc. Dr. Turan has received publishing royalties from a publication relating to health care. Dr. Turan has received publishing royalties from a publication relating to health care.
Johanna T. Fifi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Neha Dangayach, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dangayach has nothing to disclose.
Jessica Ailani, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Rebecca Spain, MD, MSPH, FÂ鶹´«Ã½Ó³»­ Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Teneille Gofton, MD The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Achim Berthele, MD No disclosure on file
Cheryl Hemingway Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jennifer McGuire, MD Dr. McGuire has received research support from NIH.
Sami L. Khella, MD, FÂ鶹´«Ã½Ó³»­ Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Mia T. Minen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Oleg Butovsky, PhD No disclosure on file
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Seemant Chaturvedi, MD, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Heinz Wiendl, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Brajesh K. Lal Brajesh K. Lal has nothing to disclose.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Prabhu D. Emmady, MD, MBA No disclosure on file
Ajay Gupta, MD Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharma.
Andreas J. Plaitakis, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Norbert Goebels, MD Dr. Goebels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Goebels has received research support from Sanofi-Genzyme.
Takahiro Iizuka, MD The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Marc I. Chimowitz, MD An immediate family member of Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gore. Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo Inc. The institution of Dr. Chimowitz has received research support from NIH.
Maysaa M. Basha, MD, FÂ鶹´«Ã½Ó³»­ Dr. Basha has nothing to disclose.
Andreas Schulte-Mecklenbeck Andreas Schulte-Mecklenbeck has nothing to disclose.
Babatunde A. Ademiluyi, MD No disclosure on file
Premkumar Nattanmai Chandrasekaran, MD Dr. Nattanmai Chandrasekaran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma.
Sana Aslam, DO Dr. Aslam has nothing to disclose.
Richard H. Haas, MD Dr. Haas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SPARC. Dr. Haas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Haas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Law Firms. Dr. Haas has stock in Various Companies Stock Trading. The institution of Dr. Haas has received research support from NIH North American Mitochondrial Disease Consortium. The institution of Dr. Haas has received research support from Reneo Pharma. The institution of Dr. Haas has received research support from Astellas Pharma. The institution of Dr. Haas has received research support from Acadia Pharma. The institution of Dr. Haas has received research support from Taysha Gene Therapies. The institution of Dr. Haas has received research support from Tisento Pharma.
Neeraj Badjatia, MD The institution of Dr. Badjatia has received research support from NIH/DOD.
Neelum T. Aggarwal, MD Dr. Aggarwal has nothing to disclose.
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Virginia Schobel Virginia Schobel has nothing to disclose.
Lakshmi Warrior, MD, FÂ鶹´«Ã½Ó³»­ Dr. Warrior has nothing to disclose.
Massimo Filippi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Richard Webster No disclosure on file
Thomas Leist, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Christine D. Esper, MD, FANA, FÂ鶹´«Ã½Ó³»­ Dr. Esper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Study Group. Dr. Esper has received research support from Centers for Disease Control and Prevention. Dr. Esper has received research support from Michael J. Fox Foundation. Dr. Esper has received research support from McCamish Parkinson's Disease Innovation Program. Dr. Esper has received publishing royalties from a publication relating to health care.
Agnes Kowalska, MD Dr. Kowalska has nothing to disclose.
Rabia Malik, MD Dr. Malik has nothing to disclose.
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has nothing to disclose.
Antonio Anaya-Escamilla, MD No disclosure on file
Nicholas A. Morris, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Morris has received research support from Â鶹´«Ã½Ó³»­. The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Klaus Schmierer, MD, PhD Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Brian Koo, MD Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Liesly Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Sankar P. Gorthi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gorthi has nothing to disclose.
Louis J. Ptacek, MD Dr. Ptacek has nothing to disclose.
James F. Howard, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Alexander J. Fay, MD, PhD Dr. Fay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Retrotope. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Teladoc. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeglea. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curry Rockefeller Group. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspiro. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dwyer Hernandez. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gallagher Bassett. Dr. Fay has received research support from Sarepta. The institution of Dr. Fay has received research support from Preston-Werner Ventures.
Larisa Miller, PharmD Larisa Miller, PharmD has received personal compensation for serving as an employee of Alexion Pharmaceuticals, Inc. Larisa Miller, PharmD has received stock or an ownership interest from Alexion Pharmaceutical, Inc.
Lana Zhovtis Ryerson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Hyunmi Kim, MD Dr. Kim has nothing to disclose.
Ali Mahta, MD Dr. Mahta has received research support from Brown University Health.
John-Ross Rizzo No disclosure on file
Abdul J. Sankoh, PhD No disclosure on file
Amanda Sandoval Karamian, MD The institution of Dr. Sandoval Karamian has received research support from Pediatric Epilepsy Research Foundation.
Taha Bali, MD No disclosure on file
James P. Wymer, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Dhimant Dani, MD Dr. Dani has nothing to disclose.
Ho Jin Kim, MD Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Naresh Mullaguri, MD Dr. Mullaguri has nothing to disclose.
Jenny Lin, MD Dr. Lin has nothing to disclose.
James F. Burke, MD Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH.
George M. Plotkin, MD, PhD The institution of Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic.
Robert Mallery, MD Dr. Mallery has nothing to disclose.
Michelle Kaku, MD Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Richa Tripathi, MD Dr. Tripathi has nothing to disclose.
Shivkumar Bhadola, MD Dr. Bhadola has stock in IONIS PHARMACEUTICALS INC. Dr. Bhadola has stock in GINKGO BIOWORKS HOLDINGS INC.
Vikram Bhinder, MD No disclosure on file
Stewart A. Factor, DO, FÂ鶹´«Ã½Ó³»­ Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Jiwon Oh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Alessandro Meani Alessandro Meani has nothing to disclose.
Carol Swetlik, MD An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Amy Pace, ScD No disclosure on file
Saima Siddiqui, MD Dr. Siddiqui has nothing to disclose.
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Alberto Cucca, MD No disclosure on file
Lindsey R. Kuohn, MD Dr. Kuohn has nothing to disclose.
Hane Lee, PhD Dr. Lee has nothing to disclose.
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Colin H. Chalk, MD Dr. Chalk has nothing to disclose.
Aakash N. Bodhit, MD No disclosure on file
Brian Mac Grory, MB BCh BAO An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Cynthia X. Wang, MD Dr. Wang has nothing to disclose.
Lawrence Hewitt Lawrence Hewitt has received personal compensation for serving as an employee of Lundbeck.
Roisin Armstrong, PhD Dr. Armstrong has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.. Dr. Armstrong has received stock or an ownership interest from Alexion Pharmaceuticals Inc..
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Rami Massie, MD Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowlingwlg. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pfizer. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Argenx.
Bruce A. Perkins, MPH No disclosure on file
Kristin M. Galetta, MD Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Ding-Ding Zhang Ding-Ding Zhang has nothing to disclose.
Kelsey Satterly Kelsey Satterly has received personal compensation for serving as an employee of Impel NeuroPharma . Kelsey Satterly has received intellectual property interests from a discovery or technology relating to health care.
Jenna M. Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech Roche.
Jose G. Romano, MD, FÂ鶹´«Ã½Ó³»­ Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Shivika Chandra, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in Â鶹´«Ã½Ó³»­ Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Vishwanath Sagi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sagi has nothing to disclose.
Suyog U. Pol, PhD Dr. Pol has nothing to disclose.
Ahyuda Oh, PhD Dr. Oh has nothing to disclose.
Kevin M. Barrett, MD, FÂ鶹´«Ã½Ó³»­ Dr. Barrett has nothing to disclose.
James F. Meschia, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Jenifer Voeks Jenifer Voeks has nothing to disclose.
Alexandra S. Reynolds, MD Dr. Reynolds has nothing to disclose.
Keerthivaas Premkumar No disclosure on file
Claudia Moy, PhD Claudia Moy, PhD has nothing to disclose.
Wolfgang Brueck, PhD Dr. Brueck has nothing to disclose.
Jessika Suescun, MD Dr. Suescun has nothing to disclose.
Ifeyinwa Ani-Osheku, MBBS Dr. Ani-Osheku has nothing to disclose.
Sixto Bogantes Ledezma, MD No disclosure on file
Natalia Romano Spica Ms. Romano Spica has nothing to disclose.
Denisse G. Martinez Roque, Jr. Miss Martinez Roque has nothing to disclose.
Amin Marji, MD Dr. Marji has nothing to disclose.
Chen Chen, MD No disclosure on file
Takamichi Yamamoto, MD, PhD, FAES Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Daiichi-Sankyo.
Kai-Chen Wang Kai-Chen Wang has nothing to disclose.
Nkechi Obianozie, MBBS Dr. Obianozie has nothing to disclose.
Hussam Shaker, MD Dr. Shaker has nothing to disclose.
Madihah A. Hepburn, MD Dr. Hepburn has nothing to disclose.
Cleanthe Spanaki, MD, PhD The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PHARMABIDE/SPECIFAR-TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALLERGAN. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ITF. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received research support from ABBVIE.
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Dalia Rotstein, MD Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from National MS Society. Dr. Rotstein has received research support from Li Ka Shing Knowledge Institute. The institution of Dr. Rotstein has received research support from University of Toronto Division of Neurology. The institution of Dr. Rotstein has received research support from Canada's Drug Agency. The institution of Dr. Rotstein has received research support from Amgen. The institution of Dr. Rotstein has received research support from Alexion. The institution of Dr. Rotstein has received research support from Guthy Jackson Foundation .
Jimmy Holder, MD Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
Ying-Hui Fu, PhD No disclosure on file
Gianna Carla Riccitelli No disclosure on file
Liying Cui, PhD No disclosure on file
Ali Saad, MD, FÂ鶹´«Ã½Ó³»­ Dr. Saad has nothing to disclose.
Milton Biagioni, MD No disclosure on file
Brijesh P. Mehta, MD Dr. Mehta has nothing to disclose.
Kush Sharma, MBBS Dr. Sharma has nothing to disclose.
Natalia Totolyan, MD Dr. Totolyan has received research support from Alexion. The institution of Dr. Totolyan has received research support from Biocad (Russia). The institution of Dr. Totolyan has received research support from Janssen. The institution of Dr. Totolyan has received research support from MAPI Pharma LTD. The institution of Dr. Totolyan has received research support from Merck. The institution of Dr. Totolyan has received research support from Novartis. Dr. Totolyan has received research support from Roche. The institution of Dr. Totolyan has received research support from Receptos. The institution of Dr. Totolyan has received research support from Sanofi. The institution of Dr. Totolyan has received research support from TG-Therapeutics.
Ralph L. Sacco, MD, MS, FAHA Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Nassim Zecavati, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zecavati has nothing to disclose.
Muhammad W. Anjum, MD Dr. Anjum has nothing to disclose.
Stelios M. Smirnakis, MD, PhD An immediate family member of Dr. Smirnakis has received personal compensation for serving as an employee of Biogen Inc.. An immediate family member of Dr. Smirnakis has received stock or an ownership interest from Biogen. Dr. Smirnakis has received stock or an ownership interest from Photomedics Inc. The institution of Dr. Smirnakis has received research support from NIH. The institution of Dr. Smirnakis has received research support from Veterans Administration. The institution of Dr. Smirnakis has received research support from Emmetropia Inc. Dr. Smirnakis has received personal compensation in the range of $100,000-$499,999 for serving as a neurology staff with Veterans Administration.
Daniel Sacchetti, DO, FÂ鶹´«Ã½Ó³»­ Dr. Sacchetti has nothing to disclose.
Brian Werneburg Mr. Werneburg has received personal compensation for serving as an employee of Stoke Therapeutics.
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Andrew D. Campbell, PhD No disclosure on file
Wendy G. Mitchell, MD Dr. Mitchell has nothing to disclose.
Linda C. Wendell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Murat Terzi, PhD Dr. Terzi has nothing to disclose.
L C. Pettigrew, MD, MPH, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Victor J. Del Brutto, MD The institution of Dr. Del Brutto has received research support from Florida Health Department. The institution of Dr. Del Brutto has received research support from american heart association.
Michael Reznik, MD Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Steve Kanes, MD, PhD Dr. Kanes has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Kanes has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Verge Genomics. Dr. Kanes has received intellectual property interests from a discovery or technology relating to health care.
Charles H. Adler, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Holly A. Shill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Jeffrey M. Kornitzer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kornitzer has nothing to disclose.
Tanja D. Kuhlmann, MD No disclosure on file
Wazim Mohamed, MD Dr. Mohamed has nothing to disclose.
Riadh Gouider, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Navdeep Sangha, MD Dr. Sangha has nothing to disclose.
James McGinley James McGinley has received personal compensation for serving as an employee of Vector Psychometric Group, LLC. An immediate family member of James McGinley has received personal compensation for serving as an employee of UPMC Children's Community Pediatrics. James McGinley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for McGinley Statistical Consulting, LLC. James McGinley has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Cephalalgia (journal). James McGinley has stock in various companies. The institution of James McGinley has received research support from National Headache Foundation.
Gabriel Torrealba Acosta, MD Dr. Torrealba Acosta has nothing to disclose.
David Q. Beversdorf, MD, FÂ鶹´«Ã½Ó³»­ Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Catherine Monigan, DO Dr. Monigan has nothing to disclose.
Susanne Muehlschlegel, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with Â鶹´«Ã½Ó³»­. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Andrew D. Hershey, MD, PhD, FAHS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Alessandro Di Rocco, MD Dr. Di Rocco has nothing to disclose.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Katarina B. Dakay, DO No disclosure on file
Norianne Pimentel, MD No disclosure on file
Oscar R. Benavente, MD, FRCP(C) No disclosure on file
Leigh Ramos-Platt, MD, MBA Dr. Ramos-Platt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Ramos-Platt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Ramos-Platt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cure sma. Dr. Ramos-Platt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Ramos-Platt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Ramos-Platt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MyTomorrows.
Randall Edgell, MD Dr. Edgell has nothing to disclose.
Christina L. Szperka, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from PCORI. Dr. Szperka has a non-compensated relationship as a Cochair Scientific Committee with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Kirk W. Johnson, PhD No disclosure on file
Amelia Carwin, MD Dr. Carwin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Carwin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin.
Gisbert Weckbecker No disclosure on file
Marcus Yountz, MD, FÂ鶹´«Ã½Ó³»­ Dr. Yountz has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Yountz has stock in AstraZeneca.
Nichelle Raj Nichelle Raj has nothing to disclose.
Francis Tirol, MD No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Yoshimi Sogawa, MD Dr. Sogawa has nothing to disclose.
Manoj Malhotra, MD Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Clement Francois No disclosure on file
Adnan Subei, DO, FÂ鶹´«Ã½Ó³»­ Dr. Subei has received personal compensation for serving as an employee of Neurology Consultants of Dallas. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Efficient. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Meyer Squibb. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Subei has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Subei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Tina M. Burton, MD Dr. Burton has nothing to disclose.
Mandip S. Dhamoon, MD, MPH Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Shishir K. Rao, MD The institution of Dr. Rao has received research support from Eisai, Inc.
Kaitlin Reilly-Kit, MD Dr. Reilly-Kit has nothing to disclose.
Kelly-Ann Patrice, MBBS Dr. Patrice has nothing to disclose.
Julia Rybkina No disclosure on file
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Farhan Siddiq, MD Dr. Siddiq has nothing to disclose.
Akira Machida No disclosure on file
Shilpa Haldal, MD Dr. Haldal has nothing to disclose.
Anusha Yeshokumar, MD Dr. Yeshokumar has nothing to disclose.
Dejan Jakimovski, MD, PhD Dr. Jakimovski has nothing to disclose.
Tom Fuchs Mr. Fuchs has nothing to disclose.
Parul Agarwal Parul Agarwal has nothing to disclose.
Ingo Kleiter Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall.
Danielle J. Kellier The institution of Ms. Kellier has received research support from National Institute of Neurological Disorders and Stroke.
Laura A. Kirkpatrick, MD The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Dina Namiranian, MD Dr. Namiranian has nothing to disclose.
Alejandro Salah, MD, PhD, MBA, MHA Dr. Salah has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma.
Tuba Rashid Khan, MD Dr. Rashid Khan has nothing to disclose.
Saleem M. Al Mawed, MD Dr. Al Mawed has nothing to disclose.
Viviana Jimenez, MD Dr. Jimenez has nothing to disclose.
Hajime Ito No disclosure on file
Monica Alcantara, MD No disclosure on file
Veronica Anania, PhD Dr. Anania has received personal compensation for serving as an employee of Genentech. Dr. Anania has stock in Roche.
Sara Mariotto, MD, PhD Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, Â鶹´«Ã½Ó³»­. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM.
Safa Kaleem, MD Dr. Kaleem has nothing to disclose.
Brenda L. Banwell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Alejandro E. Caride No disclosure on file
Guillermo Izquierdo Ayuso, MD Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Krishna Nalleballe, MD, FÂ鶹´«Ã½Ó³»­ Dr. Nalleballe has nothing to disclose.
Serdar Ceylaner Serdar Ceylaner has nothing to disclose.
Aliya Frederick, MD, PhD No disclosure on file
Carrie R. Houts Carrie R. Houts has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Jacklyn Johnson, MD Dr. Johnson has nothing to disclose.
Rohan Sharma, MD Dr. Sharma has nothing to disclose.
Nicholas Schwab The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Michael E. Newmark, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Marius Ringelstein Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Nidhi Kapoor, MD, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Kapoor has nothing to disclose.
Nan Zhang Nan Zhang has nothing to disclose.
Poornachand Veerapaneni, MD Dr. Veerapaneni has nothing to disclose.
Gerald A. Onwuegbuzie, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Saurabh Kataria, MD Dr. Kataria has nothing to disclose.
Arwa Rekik, MD No disclosure on file
Horacio Chapa-Martinez No disclosure on file
Maryum Shoukat, MD Dr. Shoukat has nothing to disclose.
Takahisa Mikami, MD Dr. Mikami has nothing to disclose.
Ian Cossentino, BS No disclosure on file
Alinna J. Sam No disclosure on file
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Jayoung Pak, MD No disclosure on file
Tania Bruno No disclosure on file
Peter S. Tatum, DO No disclosure on file
Dana Haagen No disclosure on file
Meghan Hutch No disclosure on file
Gaurav Chattree, MD Dr. Chattree has nothing to disclose.
Kevin N. Vanent Mr. Vanent has nothing to disclose.
Lucretia Long, DNP, APRN-CNP, FAES Mrs. Long has received personal compensation for serving as an employee of SKLife. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SKLife. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst Pharmaceutical. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Liva Nova. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK lIFE. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Liva Nova.
Caroline L. Medeiros, Jr., MD Dr. Medeiros has nothing to disclose.
Eliot A. Licht, MD No disclosure on file
Hisham G. Elkhider, MD Dr. Elkhider has nothing to disclose.
Ben Djebara Mouna No disclosure on file
Anna Lee No disclosure on file
Mahya Beheshti, MBBS No disclosure on file
Scott Moody No disclosure on file
Sara Pavitt, MD An immediate family member of Dr. Pavitt has received personal compensation for serving as an employee of NuvieBio. An immediate family member of Dr. Pavitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. The institution of Dr. Pavitt has received research support from PCORI.
Paige Sutton, MD Dr. Sutton has nothing to disclose.
Christian Gericke, MD PhD MPH, FÂ鶹´«Ã½Ó³»­ Dr. Gericke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medicines Australia. Dr. Gericke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Australian Hospital and Healthcare Association. Dr. Gericke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Australian Government Agencies.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Traci Kazmerski The institution of Traci Kazmerski has received research support from Cystic Fibrosis Foundation. The institution of Traci Kazmerski has received research support from NIH.
Sian Lennon-Chrimes No disclosure on file
Ali Hamzehloo, MD Dr. Hamzehloo has nothing to disclose.
Hanife Saglam, MD Dr. Saglam has nothing to disclose.
Amardeep Saund, MD Dr. Saund has nothing to disclose.
Kyle M. Blackburn, MD Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx.
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Babak Navi, MD Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Chris Hollen, MD Dr. Hollen has nothing to disclose.
Jennifer Kang, MD Dr. Kang has nothing to disclose.
Adrian Handforth, MD No disclosure on file
Roman Pulyk No disclosure on file
Mashael O. Khateeb, MD Dr. Khateeb has nothing to disclose.
Kayihan Uluc, MD Dr. Uluc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Lawrence Cook, PhD The institution of Dr. Cook has received research support from CDC. The institution of Dr. Cook has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Cook has received research support from Utah Highway Safety Office. The institution of Dr. Cook has received research support from NIH.
Stacey Clardy, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/Â鶹´«Ã½Ó³»­ Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ Summer Meeting CoDirector Travel and Lodging with Â鶹´«Ã½Ó³»­. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Eduardo A. De Sousa, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Panayiotis Mitsias, MD The institution of Dr. Mitsias has received research support from European Union.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mayela D. Rodriguez Violante, MD Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rodriguez Violante has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sandoz Novartis. Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zydus. The institution of Dr. Rodriguez Violante has received research support from LARGE-PD.
Robert Kadish, MD Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Syeda Maria Muzammil, MD Dr. Muzammil has nothing to disclose.
Jennifer Robinson No disclosure on file
Agnieszka Kielian, MD Dr. Kielian has nothing to disclose.
Olivier Heinzlef, MD Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Edimark.
Sookyong Koh, MD, PhD No disclosure on file
Rebecca L. Gillani, MD The institution of Dr. Gillani has received research support from The Phyllis and Jerome Lyle Rappaport Foundation. The institution of Dr. Gillani has received research support from McCourt Foundation . The institution of Dr. Gillani has received research support from Roche.
Zaganas Ioannis, DO No disclosure on file
Sung-Min Cho, DO Dr. Cho has nothing to disclose.
Celia Oreja Guevara Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for viatris. Celia Oreja Guevara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for biogen. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bms. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for jannsen.
Dina Dababneh, MD No disclosure on file
Maria F. Ghilardi, MD No disclosure on file
Bradford B. Thompson, MD Dr. Thompson has nothing to disclose.
Shaweta Khosa Ms. Khosa has nothing to disclose.
Surabhi Kaul, MD No disclosure on file
Jagannadha R. Avasarala, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Avasarala has received personal compensation in the range of $10,000-$49,999 for serving as a Expert analyst with DOJ.
Shawna M. Cutting, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cutting has received research support from Genentech.
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Blanca Marquez de Prado An immediate family member of Blanca Marquez de Prado has stock in Latus Bio. An immediate family member of Blanca Marquez de Prado has received intellectual property interests from a discovery or technology relating to health care.
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Christopher Silber No disclosure on file
Shannon M. Beres, MD Dr. Beres has nothing to disclose.
Ashkan Shoamanesh, MD Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer AG. Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo . Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier Inc.. Dr. Shoamanesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurodiem.ca. The institution of Dr. Shoamanesh has received research support from Servier Canada Inc.. The institution of Dr. Shoamanesh has received research support from Daiichi Sankyo Ltd.. The institution of Dr. Shoamanesh has received research support from Bayer AG. The institution of Dr. Shoamanesh has received research support from Bristol-Myers Squibb. The institution of Dr. Shoamanesh has received research support from Octapharma Canada .
Itay Lotan, MD Dr. Lotan has nothing to disclose.
Robert W. Charlson, MD Dr. Charlson has nothing to disclose.
Zain Guduru, MD, FÂ鶹´«Ã½Ó³»­ Dr. Guduru has nothing to disclose.
Frank Diaz, MD, PhD Dr. Diaz has nothing to disclose.
Ferdinand Schweser, PhD Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Hema Viswanathan Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
Jeff Jonas No disclosure on file
Kevin N. Sheth, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Alessandro Biffi, MD Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Charlene J. Ong, MD Dr. Ong has nothing to disclose.
Shyam S. Rao, MD No disclosure on file
Emmanuelle R. Tiongson, MD Dr. Tiongson has nothing to disclose.
Robert Freundlich, MD Dr. Freundlich has nothing to disclose.
Christine Stadelmann-Nessler No disclosure on file
Imen Kacem, MD Dr. Kacem has nothing to disclose.
Tamar Bacon The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Melanie Korsen No disclosure on file
John Liang, MD Dr. Liang has nothing to disclose.
Luisa H. Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Leticia Alejandra Olguín-Ramírez, Jr. No disclosure on file
Maria Alejandra Gonzalez Duarte, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Stanley Tuhrim, MD No disclosure on file
RJ Wirth, PhD RJ Wirth has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.
Necdet H. Karli, MD No disclosure on file
Danielle A. Becker, MD Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Daniel Glaze, MD Dr. Glaze has nothing to disclose.
Rodger J. Elble, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Serefnur Ozturk, MD No disclosure on file
Daniel E. Okobi, Jr., MD, PhD Dr. Okobi has received research support from UCLA.
Elham Abushanab, MD Dr. Abushanab has nothing to disclose.
MARIA JOSE MORENO JIMENEZ No disclosure on file
Stephanie Rutrick, MD The institution of Dr. Rutrick has received research support from Roche. The institution of Dr. Rutrick has received research support from Lilly. The institution of Dr. Rutrick has received research support from Athira. The institution of Dr. Rutrick has received research support from Abbvie.
Oscar Esquivel, MD Mr. Esquivel has nothing to disclose.
Ayse Dikicibasi Koc, MD No disclosure on file
Yaprak Secil, MD No disclosure on file
Jafar Hashem, MD Dr. Hashem has nothing to disclose.
Steven T. Bellows, MD The institution of Dr. Bellows has received research support from Takeda Pharmaceuticals. The institution of Dr. Bellows has received research support from Sage Therapeutics. The institution of Dr. Bellows has received research support from Bukwang Pharmaceutical . The institution of Dr. Bellows has received research support from AbbVie.
Abigail Lofchie, MD No disclosure on file
Omaira Molina, MD No disclosure on file
Ihsan Sukru Sengun, MD No disclosure on file
AYSE OYTUN BAYRAK No disclosure on file
Arnold J. Sansevere, MD Dr. Sansevere has nothing to disclose.
Barbara Schaeffler No disclosure on file
Markus Reindl, PhD The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
James F. Paskavitz, MD No disclosure on file
Margaret S. Lee, PhD No disclosure on file
Sairah Bashir, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bashir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Kimberly A. Parkerson, MD, PhD Dr. Parkerson has received personal compensation for serving as an employee of Stoke Therapeutics. Dr. Parkerson has stock in Stoke Therapeutics.
Nina J. Solenski, MD Dr. Solenski has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Multiple. The institution of Dr. Solenski has received research support from HRSA . Dr. Solenski has received intellectual property interests from a discovery or technology relating to health care.
Duriel I. Hardy, MD Dr. Hardy has nothing to disclose.
Angela M. Hawkins, RN No disclosure on file
Peter C. Mabie, MD Dr. Mabie has nothing to disclose.
Basilio Hernandez No disclosure on file
Juan Pablo Pettinicchi, MD No disclosure on file
Mohammad Tabaeizadeh Fesharaki, MD Dr. Tabaeizadeh Fesharaki has nothing to disclose.
Mehmet Ali Akalin No disclosure on file
Susana Lopez No disclosure on file
Edgar Carnero Contentti Edgar Carnero Contentti has nothing to disclose.
Nancy Santilli, RN, PNP, MN No disclosure on file
Jeffrey Neul, MD, PhD Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alcyone. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid. Dr. Neul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Neul has stock in LizardBio. The institution of Dr. Neul has received research support from NIH. The institution of Dr. Neul has received research support from Acadia. The institution of Dr. Neul has received research support from GW Pharmaceuticals. The institution of Dr. Neul has received research support from International Rett Syndrome Foundation. The institution of Dr. Neul has received research support from Rett Syndrome Research Trust.
R Arturo Abundes-Corona, MD Dr. Abundes-Corona has nothing to disclose.
Ton J. DeGrauw, MD No disclosure on file
Jina M. Youn, MD, MS Dr. Youn has nothing to disclose.
Guido Sabatella Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Tyler Koehn, MD Dr. Koehn has nothing to disclose.
Srinivasa Rao Kundeti Srinivasa Rao Kundeti has nothing to disclose.
Sara M. Schaefer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. The institution of Dr. Schaefer has received research support from American Parkinson Disease Association. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a RITE Section Lead with Â鶹´«Ã½Ó³»­. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a QOD Question Writer with Â鶹´«Ã½Ó³»­.
Jacinta Behne Ms. Behne has nothing to disclose.
Nada Ahmed, MD Dr. Ahmed has nothing to disclose.
Anthony K. Ma, MD Mr. Ma has nothing to disclose.
Sunil H. Rathore, MD Dr. Rathore has nothing to disclose.
John Kollins No disclosure on file
MINAS TZAGOURNISAKIS No disclosure on file
Karissa Johnston Karissa Johnston has nothing to disclose.
Mohamed I. Kandil, MD No disclosure on file
Carmen Vizzino No disclosure on file
Leila Ghaffari, MD Dr. Ghaffari has nothing to disclose.
Adrian Kielhorn Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Francesca Macaluso No disclosure on file
Tobias Zrzavy Tobias Zrzavy has nothing to disclose.
Romana Hoeftberger Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology: Neuroimmunology and Neuroinflammation. Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with BMS and UCB Biopharma.
Melih Tutuncu, MD Dr. Tutuncu has nothing to disclose.
Sandra M. Torres, Sr., MD No disclosure on file
Cynthia G. Sarabia-tapia, MD No disclosure on file
Naiade Couto, MD Dr. Couto has nothing to disclose.
Yazmin Rios-Solis No disclosure on file
Grace Trentin, PhD No disclosure on file
Bhageeradh Mulpur, MD Dr. Mulpur has nothing to disclose.
Madeleine Klein, BS The institution of an immediate family member of Madeleine Klein has received research support from NIH.
Gregory Fenton, MD No disclosure on file
Vanessa Barriga Maldonado, Sr., PhD No disclosure on file
Simona Treidler, MD Dr. Treidler has nothing to disclose.
Kenneth Griffin, MD No disclosure on file
Matthew R. Woodward, DO Dr. Woodward has nothing to disclose.
Kevin C. O'Connor, PhD Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Immunovant. Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Kevin C. O'Connor, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurocrine. Kevin C. O'Connor, PhD has stock in Cabaletta. The institution of Kevin C. O'Connor, PhD has received research support from Seismic. The institution of Kevin C. O'Connor, PhD has received research support from Argenx. Kevin C. O'Connor, PhD has received intellectual property interests from a discovery or technology relating to health care.
Roger Kaprielian Roger Kaprielian has nothing to disclose.
Chrysoula Zografou No disclosure on file
Anjali Sharma No disclosure on file
Puja Agarwal, PhD, MBA Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Advocate Health. The institution of Dr. Agarwal has received research support from NIH/NIA.
Shannon Strom Shannon Strom has received personal compensation for serving as an employee of Satsuma Pharmaceuticals. Shannon Strom has received personal compensation in the range of $0-$499 for serving as a Consultant for Arena Pharmaceuticals. Shannon Strom has stock in Satsuma Pharmaceuticals.
Mohamed Elfil, MBBCh Dr. Elfil has nothing to disclose.
Daniel Davila-Williams, MD Dr. Davila-Williams has nothing to disclose.
Daniela Pohl Daniela Pohl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos.
Kenneth P. Martinez, MD The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan.
Douglas Bernhard No disclosure on file
Aditi Sharma, MBBS Dr. Sharma has nothing to disclose.
Martha C. Morris, ScD No disclosure on file
Jane Shaji, MD No disclosure on file
Rebekah Proctor No disclosure on file
Jessica Houck, DO No disclosure on file
Jamie Ghossein No disclosure on file
Fan Zhang, DO No disclosure on file
Jacqueline Li, MD No disclosure on file
Samuel J. Mackenzie, MD, PhD Dr. Mackenzie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phlow, Corp. Dr. Mackenzie has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Everyday Health, Inc. Dr. Mackenzie has received intellectual property interests from a discovery or technology relating to health care.
Michelle Sahagian, MD No disclosure on file
Ramdinal A. Zairinal, MD Dr. Zairinal has received research support from Ristek-BRIN and LPDP.
Dejan Budimirovic No disclosure on file
Sung Chul Lim Sung Chul Lim has nothing to disclose.
Hernan Nicolas Lemus Esquivel, MD Dr. Lemus Esquivel has nothing to disclose.
Linda Nguyen, MD, PhD Dr. Nguyen has nothing to disclose.
Vamshi Krishna Sai Balasetti, MD No disclosure on file
Fatima I. Abdulai, MBBS Dr. Abdulai has nothing to disclose.
Errol L. Gordon, MD No disclosure on file
Tania Kuempfel, MD Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon.
Churl-Su Kwon, MBBS Dr. Kwon has nothing to disclose.
David A. Marks, MD Dr. Marks has nothing to disclose.
Niraj A. Arora, MD Dr. Arora has nothing to disclose.
Peter Alabi, Sr., MBBS, FMCP Dr. Alabi has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Norvatis.
Andrea Hidalgo, MD Dr. Hidalgo has nothing to disclose.
Vishank A. Shah, MD Dr. Shah has nothing to disclose.
Sen Sheng, MD Dr. Sheng has nothing to disclose.
Shanthi Viswanathan No disclosure on file
Xin Yang, MD, PhD Dr. Yang has nothing to disclose.
Fumiyoshi Iwashima No disclosure on file
Akanksha Mittal, PhD No disclosure on file
Etienne Leveille, MD No disclosure on file
Imran Tanvir Imran Tanvir has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Imran Tanvir has received stock or an ownership interest from Alexion Pharmaceuticals.
Maria Sokola, MD Dr. Sokola has nothing to disclose.
Koji Takahashi, PhD Dr. Takahashi has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Takahashi has stock in Cerevel Therapeutics.
Donald Bushnell No disclosure on file
Daniela Stokmaier Daniela Stokmaier has received personal compensation for serving as an employee of Roche.
Timothy A. Benke, MD, PhD The institution of Dr. Benke has received research support from NIH, RSRT, IRSF and Children's Hospital Colorado. The institution of Dr. Benke has received research support from Acadia, GW, RSRT, Ovid/Takeda, Marinus. The institution of Dr. Benke has received research support from Acadia, CUREGRI, GRINtherapeutics, GW, IRSF, Marinus, Neurogene, Taysha, Ultragenyx and Zogenix/UCB; .
William B. Young, MD, FÂ鶹´«Ã½Ó³»­ Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Veronica A. Tkachuk Veronica A. Tkachuk has nothing to disclose.
Rujuta B. Wilson, MD Dr. Wilson has nothing to disclose.
Mark Versavel, MD, PhD An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
James M. Youakim, MD Dr. Youakim has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Youakim has stock in Acadia Pharmaceuticals.
Jennifer Petrillo Billet, PhD Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
Christa B. Swisher, MD Dr. Swisher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Nazanin Kiapour, MD Dr. Kiapour has nothing to disclose.
Cagdas Erdogan No disclosure on file
N. Abimbola Sunmonu, MD, PhD Dr. Sunmonu has nothing to disclose.
Emma Burdekin No disclosure on file
Spyros Papapetropoulos No disclosure on file
George Plummer, MD Dr. Plummer has nothing to disclose.
K. H. Vincent Lau, MD Dr. Lau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Lau has or had stock in Alnylam Pharmaceuticals.
Chen Yan, MD Dr. Yan has nothing to disclose.
Michael R. Yeaman, PhD Dr. Yeaman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech-Roche. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Yeaman has received research support from National Institutes of Health. The institution of Dr. Yeaman has received research support from U.S. Department of Defense. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care.
Emilio R. Garrido Sanabria, MD, PhD Dr. Garrido Sanabria has nothing to disclose.
Chun Chieh Lin, PhD The institution of Dr. Lin has received research support from Â鶹´«Ã½Ó³»­. The institution of Dr. Lin has received research support from Genentech Inc. The institution of Dr. Lin has received research support from NIH.
Terry Smith Terry Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Horizon. Terry Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunovant. Terry Smith has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Terry Smith has received intellectual property interests from a discovery or technology relating to health care.
Anuradha Singh, DO Dr. Singh has nothing to disclose.
Fernando Morales-Ramírez No disclosure on file
Detlef Albrecht Detlef Albrecht has received personal compensation for serving as an employee of Satsuma. Detlef Albrecht has stock in Satsuma.
Soumya S. Yandamuri, PhD Dr. Yandamuri has nothing to disclose.